4.8 Article

FeS nanoplates as a multifunctional nano-theranostic for magnetic resonance imaging guided photothermal therapy

Journal

BIOMATERIALS
Volume 38, Issue -, Pages 1-9

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2014.10.052

Keywords

Iron sulfide nanoplates; Magnetic resonance imaging; Photothermal therapy; Cancer theranostics

Funding

  1. Soochow University and Research Grants Council of Hong Kong SAR - CRF Grant [CityU5/CRF/08]
  2. National Natural Science Foundation of China [51302180, 51222203, 51132006, 21207164, 31400861, 81471716]
  3. National 973 Program of China [2011CB911002, 2012CB932601, 2014CB931900]
  4. Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)

Ask authors/readers for more resources

In this work, we develop magnetic iron sulfide (FeS) nanoplates as a theranostic agent for magnetic resonance (MR) imaging-guided photothermal therapy of cancer. FeS nanoplates are synthesized via a simple one-step method and then functionalized with polyethylene glycol (PEG). The obtained PEGylated FeS (FeS-PEG) nanoplates exhibit high NIR absorbance together with strong superparamagnetism. The r2 relaxivity of FeS-PEG nanoplates is determined to be 209.8 mm-1S-1, which appears to be much higher than that of iron oxide nanoparticles and several types of clinical approved T2-contrast agents. After intravenous (i.v.) injection, those nanoplates show high accumulation in the tumor as revealed by MR imaging. Highly effective photothermal ablation of tumors is then achieved in a mouse tumor model upon i.v. injection of FeS-PEG at a moderate dose (20 mg/kg) followed by 808-nm NIR laser irradiation. Importantly, it has been found that PEGylated FeS nanoplates after systemic administration could be gradually excreted from major organs of mice, and show no appreciable toxicity to the treated animals even at a dose (100 mg/kg) 5 times as high as that used for imaging & treatment. Our results demonstrate that PEGylated FeS nanoplates may be a promising class of theranostic nano-agents with a good potential for future clinical translation. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available